fibrolamellar

fibrolamellar

/fi·bro·la·mel·lar/ (fi″bro-lah-mel´er) characterized by the formation of fibers of collagen in layers.
Mentioned in ?
References in periodicals archive ?
In comparison with conventional HCC, fibrolamellar variant is usually negative for AFP, less frequently positive for GPC3, and more frequently positive for CK7.
The central scar may mimic a collagenous scar seen in fibrolamellar carcinoma, hepatic adenoma, HCC or cholangiocarcinoma due to obliterative vascular hyperplasia of the central scar.
Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
BENIGN MALIGNANT EPITHELIAL Focal nodular Hepatoblastoma hypoplasia Hepatocellular Hepatocellular carcinoma adenoma Nodular Fibrolamellar regenerative carcinoma hyperplasia Mixed hamartoma Developmental cysts MESENCHYMAL Infantile Undifferentiated/ hemangioendothelioma embryonal sarcoma Mesenchymal Angiosarcoma hamartoma Cavernous Rhabdomyosarcoma hemangioma Infantile Rhabdoid tumor pseudotumor GERM CELL TUMORS TERATOMA Endodermal sinus tumor
Almany MR, Reznikova N, Shahar R, Weiner S (2014) Three-dimensional structure of minipig fibrolamellar bone: adaptation to axial loading.
Tragic Doyne with She was diagnosed with a rare liver cancer called fibrolamellar hepatocellular carcinoma in November 2011 and underwent surgery but months later began to feel extremely unwell again.
Casi Pharmaceuticals (NASDAQ:CASI), a biopharmaceutical company, has filed an application with China's Food and Drug Administration for the approval to conduct a phase II clinical trial of its drug candidate, ENMD-2076, in fibrolamellar carcinoma patients, it was reported on Friday.
Based on the clinical and imaging findings, the differential diagnosis of PHL may include: hepatic adenoma, focal nodular hyperplasia, fibrolamellar carcinoma, hemangioma or hepatocellular carcinoma (Table1).
Further investigations confirmed a liver tumour in segment IV, which was confirmed to be a fibrolamellar hepatoma.
The Oranmore student is currently cancer free but because Fibrolamellar has a 90% recurrence rate it is crucial she is monitored closely.
Only about 200 people a year worldwide are diagnosed, according to the Fibrolamellar Cancer Foundation, which helped fund the new study.
Within the superficial dermis, the prevalence of fibrolamellar hyperplasia increased from 19% in nonlymphedematous legs to 50% in stage 1 lymphedema but remained similar for stages 1-3.